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To Filter or Not To Filter 
Background/Significance 
▪ At LVHN, there were 27 phlebitis 
incidences directly related to IV 
amiodarone infusions in a three year 
period on 3A/IPCU, PCU and CICU.  
▪ Current practice at LVHN does not include 








▪ In patients receiving intravenous 
amiodarone, does the use of in-line filters 
reduce the incidence of phlebitis? 
▪ P:  Patients receiving intravenous amiodarone 
▪  I:  Infusion through in-line filter 
▪ C:  Infusion through peripheral lines without an in-line filter           
▪ O:  Decreased incidence of phlebitis 
Purpose 
▪ To decrease IV phlebitis in patients 
receiving IV amiodarone.  
TRIGGER? 
▪ Knowledge v. Problem 
• Problem focused  
• The trigger for this project is problem 
focused. At LVHN there were 27 
phlebitis incidences directly related to 
IV amiodarone infusions in a three year 
period on three cardiac units (3A/IPCU, 
PCU and CICU).  
 
EVIDENCE 
▪ EBSCO CINAHL and OVID Medline were the search 
engines primarily utilized to gain evidence for this project. 
 
▪ Keywords utilized to obtain evidence were the following: 
amiodarone, phlebitis, in-line filters, and infusion. 
 
▪ Data was reviewed and synthesized from eight current 
research articles on the topic of amiodarone infusions to 
gain knowledge on the subject. 
 
▪ Current literature recommends an in-line filter be utilized 





▪ Risk factors of phlebitis can be related to the 
infusion of certain caustic medications.  The 
nurse can have an impact on prevention. 
 
▪ The incidence of phlebitis and infiltration is 
tracked through the utilization of scales/data. 
 
▪ Alternative delivery methods such as in-line filters 
may decrease the incidence of phlebitis, therefore 
improving quality and decreasing costs. 
 
▪ Nurses must be aware of the impact of caustic 





 ▪ Studies have shown an increased incidence of 
phlebitis in patients receiving amiodarone 
peripherally. 
▪ Researchers have found that in-line filters are a 
necessary component when administering 
amiodarone. 
▪ A retrospective chart review was conducted at a 
large military hospital on 273 patients receiving 
amiodarone therapy and found that phlebitis is a 
significant complication associated with 





Current Practice at LVHN 
▪ Current practice at LVHN is to utilize  
tubing without an in-line filter to infuse IV 
amiodarone.  
IMPLEMENTATION 
1. Process Indicators and Outcomes  
▪ In-line filters and phlebitis scores 
2. Baseline Data 
▪ Safety reports from 3A/IPCU, PCU and 
CICU for the last three years (1/1/11- 
12/31/13) were analyzed to determine 
the number (N=27) of IV infiltrates that 
were related to amiodarone. 
 
IMPLEMENTATION 
3. Design (EBP) Guideline(s)/Process 
▪ Adding an in-line filter to the end of our  
current tubing to infuse IV amiodarone. 
▪ Data will be collected and analyzed to see 
if the utilization of an in-line filter with IV 
amiodarone infusion decreases the 
incidence of phlebitis.  
 
IMPLEMENTATION 
4. Implemented EBP on Pilot Units 
▪ A pilot study was initiated on March 
31,2014 for CICU and 3A/IPCU to include 
the use of an in-line filter for all peripheral 
IV amiodarone infusions. 
▪ The nurses on 3A/IPCU and CICU were in-
serviced on this pilot study by the 3A/IPCU 
PCS.   Log books were created for both 
units for data collection purposes. 
 
IMPLEMENTATION 
5. Evaluation (Post data) of Process & Outcomes 
 
▪ Data will be collected and analyzed to determine 
whether the use of an in-line filter with IV amiodarone 
infusions decreases the incidence of phlebitis. 
 
6. Modifications to the Practice Guideline 
 
▪ At this time, no practice guidelines at LVHN are being 




7. Network Implementation 
▪ Our plan is to continue the pilot study on 
the two units until September 30, 2014 to 
potentially enroll a larger number of 
patients into the study. 
▪ Currently in-line filters have been utilized 
on 18 patients.  So far, only one infiltration 
has occurred.  This particular infiltrate 
occurred in a patient with a pre-hospital IV. 
 
Practice Change 
▪ This study hopes to change the practice at 
LVHN for IV amiodarone infusion with the 
utilization of an in-line filter. 
▪ This practice change will benefit the 
patients by decreasing their risk of 
phlebitis. 
RESULTS 
▪ Key Findings: Results are pending in hope 
that utilization of in-line filters will 
significantly decrease the incidence of 
phlebitis with amiodarone infusions. 
▪ Next steps: Continuing the pilot study, 
collecting, and analyzing the data.  
Implications for LVHN 
▪ This practice change could potentially: 
• Increase patient satisfaction 
• Decrease length of stay 
• Decrease cost of treatment 
Strategic Dissemination of Results 
■ PLAN for DISSEMINATION 
■ Sharing pilot study results with Pharmacy Safety 
Officer at LVHN. 
■ Present findings to LVHN Practice Council for 
network wide approval. 
■ Present pilot study process to Patient Care 
Specialists (PCSs) at monthly PCS meeting. 
■ Create TLC course and coordinate in-services to 
units that utilize IV amiodarone. 





▪ One on one education significantly 
improved compliance. 
▪ Nurses were receptive to this change in 
the hope to improve patient care. 
▪ A filter that costs $1.80 could 
potentially save the patient from 
discomfort, increased length of stay, and 
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